| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |